Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Feb 25, 2020	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	800	$447.30	25,387
Feb 25, 2020	Van Plew Daniel P EVP & General Mgr Industrial O Trans History: 359	EVP & General Mgr Industrial O	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	17,093	$447.30	43,893
Feb 24, 2020	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	786	$406.59	25,187
Feb 12, 2020	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	393	$402.34	25,080
Feb 12, 2020	STAHL NEIL EVP Research and Development Trans History: 660	EVP Research and Development	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	14,722	$402.34	21,658
Dec 12, 2019	Fenimore Christopher R. VP Controller Trans History: 306	VP Controller	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,418	$377.16	13,879
Dec 12, 2019	SCHLEIFER LEONARD S Director, President & CEO Trans History: 427	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	64,754	$377.16	384,208
Dec 12, 2019	SCHLEIFER LEONARD S Director, President & CEO Trans History: 427	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	97,209	$377.16	474,499
Dec 12, 2019	VAGELOS P ROY Director, Chairman of the Board Trans History: 742	Director, Chairman of the Board	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	55,813	$377.16	356,327
Dec 12, 2019	YANCOPOULOS GEORGE Director, President and CSO Trans History: 673	Director, President and CSO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	49,405	$377.16	371,876

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media